- Turkish Journal of Internal Medicine
- Vol: 3 Issue: 1
- Oral Glucose-Lowering Agent Treatments in Type 2 Diabetes Mellitus
Oral Glucose-Lowering Agent Treatments in Type 2 Diabetes Mellitus
Authors : Şazi Imamoğlu
Pages : 1-5
Doi:10.46310/tjim.815794
View : 11 | Download : 4
Publication Date : 2021-01-29
Article Type : Other
Abstract :Type 2 diabetes is manifested by impaired insulin secretion in pancreatic beta cells, increased glucagon secretion in alpha cells, and generally has a history of insulin resistance. The treatment of glucose metabolism disorder and the resulting hyperglycemia constitute an important part of the treatment of type 2 diabetes. Glycemic targets can be targeted with A1C <7% to reduce the risk of micro and macrovascular complications in eligible patients, and A1C <6.5% to reduce the risk of diabetic chronic renal failure and retinopathy in those with low risk of hypoglycemia. We can consider the treatment of hyperglycemia in two components; lifestyle changes and glucose-lowering agent therapy.Keywords : Type-2 diabetes, oral treatment, anti-diabetics